...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: There is hope for us
8
Jan 08, 2018 05:10PM

Great find tada, thanks.

We don't seem to see interest for apabetalone yet but perhaps the cancer area offers potential for zen3694 or other Zenith compounds.

GLTA

Toinv

Share
New Message
Please login to post a reply